Heart failure
Conditions
Interventions
Experimental group:Qisheng Yiqi Yin-yang pill
Control group:A simulated agent of Qishen Yiqi Yangyin Pills
Sponsors
Jining Hospital of Xiyuan Hospital of CACMS
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients who meet the Western medical diagnostic criteria of HFmrEF and HFpEF in chronic heart failure and NYHA cardiac function classification is grade II-III; (2) It meets the diagnostic criteria of TCM syndrome type of Qi deficiency and blood stasis syndrome; (3) between 18 and 75 years old; (4) Patients who voluntarily participated in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with new myocardial infarction acute heart failure severe valvular heart disease high atrioventricular block and other serious heart diseases or high-risk sudden death factors; (2) Patients with severe primary diseases of liver and kidney dysfunction malignant tumors blood system and other organs; (3) Severe infection such as severe pneumonia; (4) Persons with mental illness; (5) Women planning pregnancy pregnancy or breastfeeding; (6) Suspected or clear allergy to related drugs; (7) Patients who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM syndrome score;Lee heart Failure Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| NT-ProBNP;6MWT;LVEF; | — |
Countries
China
Contacts
Public ContactQu Zhengyan
Jining Hospital of Xiyuan Hospital of CACMS
Outcome results
None listed